UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000003253
Receipt number R000003768
Scientific Title Multicenter Phase II Study of FOLFOX/XELOX and Erbitux as First Line Therapy in Patients with Wild Type KRAS/BRAF Metastatic Colorectal Cancer.
Date of disclosure of the study information 2010/02/24
Last modified on 2018/09/20 08:21:37

No. Disposal Last modified on Item of update
1 Insert 2010/02/24 19:34:19
2 Update 2010/08/24 13:23:41 Address
Name of person sending information
Organization
Division name
Address
3 Update 2010/09/22 22:21:08 Public title
Acronym
Acronym
4 Update 2011/08/05 19:40:24 Recruitment status
5 Update 2012/02/24 13:41:30 Post marketing survey by drug manufacture etc., specified by Japanese law.
6 Update 2012/06/08 10:41:33 Organization
Organization
Division name
Division name
Address
Address
TEL
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
7 Update 2012/08/29 12:57:35 Email
8 Update 2013/09/01 17:52:25 Email
Last name of contact person
Last name of contact person
Address
Email
9 Update 2015/10/19 09:47:24 Recruitment status
Publication of results
Results
10 Update 2015/11/18 09:58:56 Recruitment status
Results
Other related information
11 Update 2016/04/04 16:03:14 Name of primary person or sponsor
Organization
12 Update 2018/09/20 08:21:37 Recruitment status